LmjF.36.3850, a novel hypothetical Leishmania major protein, contributes to the infection.

Zutshi, Shubhranshu; Sarode, Aditya Yashwant; Ghosh, Soumya Kanti; Jha, Mukesh Kumar; Sudan, Raki; Kumar, Sunil; Sadhale, Late Parag; Roy, Somenath; Saha, Bhaskar

Zutshi, Shubhranshu; Sarode, Aditya Yashwant; Ghosh, Soumya Kanti; Jha, Mukesh Kumar; Sudan, Raki; Kumar, Sunil; Sadhale, Late Parag; Roy, Somenath; Saha, Bhaskar.

Affiliation

Zutshi S; National Centre for Cell Science, Pune, India.
Sarode AY; National Centre for Cell Science, Pune, India.
Ghosh SK; Maulana Abul Kalam Azad University of Technology, Kolkata, India.
Jha MK; National Centre for Cell Science, Pune, India.
Sudan R; National Centre for Cell Science, Pune, India.
Kumar S; National Centre for Cell Science, Pune, India.
Sadhale LP; Indian Institute of Science, Bengaluru, India.
Roy S; Department of Human Physiology, Vidyasagar University, Midnapore, India.
Saha B; National Centre for Cell Science, Pune, India.

Immunology ; 163(4): 460-477, 2021 08.

Article de En | MEDLINE | ID: mdl-33764520

Sujet(s)
Mots clés

DNA vaccine; Leishmania; LmjF.36.3850; immunization; virulence

Texte intégral

Ajouter à My VHL

Imprimer

XML

PubMed Links

Recherche sur Google

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Vaccins antiprotozoaires / Leishmaniose cutanée / Lymphocytes T régulateurs / Leishmania major / Lymphocytes auxiliaires Th2 / Macrophages / Antigènes de protozoaire Type d'étude: Prognostic_studies Limites: Animals / Humans Langue: En Journal: Immunology Année: 2021 Type de document: Article Pays d'affiliation: Inde

Texte intégral

Ajouter à My VHL

Imprimer

XML

PubMed Links

Recherche sur Google